1 H NMR and 13 C NMR data for synthesized compounds 5, 6 and 7 S12 -S33
3-Chloro-2-methoxycyclopent-2-en-1-one (1-Cl-b)
To a solution of 1,2-cyclopentanedione (276 mg, 2.8mmol) in MeCN (28 mL) and water (2.8 mL) NCS (449 mg, 3.36 mmol) was added and the mixture was stirred for 40 h at room temperature. Water (28 mL) was then added and the mixture was extracted with CH2Cl2 (2x30 mL and 6x20 mL). The combined extracts were dried (Na2SO4) and the solvents were evaporated. Purification of the residue by column chromatography on silica gel (petroleum ether/EtOAc 10:1.5 to 10:2) gave 3-chloro-2-hydroxy-cyclopent-2-enone (351 mg, 94%), that was directly used in the next step.
To a solution of 3-chloro-2-hydroxy-cyclopent-2-enone (351 mg, 2.65 mmol) in DMF (3 mL) NaH (60% in mineral oil, 107 mg, 2.67 mmol) was added at 0 o C. After stirring for 30 min at 0 o C MeI (0.2 mL, 3.21 mmol) was added, the reaction mixture was warmed up to room temperature and stirred for 2h. Water (20 mL) was added and the mixture was extracted with CH2Cl2 (1x20 mL and 2x15 mL). The combined extracts were washed with water (10 mL), brine (10 mL) and dried (Na2SO4). The solvents were evaporated and the residue was purified by column chromatography on silica gel (petroleum ether/EtOAc 20:1 to 10:1) to give 1-Cl-b as a colorless oil (274 mg, 71% 
3-Bromo-2-methoxycyclohex-2-en-1-one (2-Br-b)
To a solution of 3-bromo-2-methoxycyclohex-2-en-1-one (458 mg, 2.4 mmol) in DMF (4 mL) NaH (60% in mineral oil, 96 mg, 2.4 mmol) was added at 0 o C. After stirring for 30 min at 0 o C MeI (0.18 mL, 2.88 mmol) was added, the reaction mixture was warmed up to room temperature and stirred for 2h. Water (15 mL) was added and the mixture was extracted with MTBE (1x20 mL and 2x15 mL). The combined extracts were washed with brine (10 mL) and dried (Na2SO4). The solvents were evaporated and the residue was purified by column chromatography on silica gel (petroleum ether/acetone 20:1) to give 2-Br-b as a yellow oil (218 mg, 44%); 1 H NMR (400 MHz, CDCl3) δ 3.75 (s, 3H), 2.91 (t, J = 6.1 Hz, 2H), 2.57 -2.47 (m, 2H), 2.09 -1.97 (m, 2H); 13 C NMR (101 MHz, CDCl3) δ 192.09, 151.07, 135.27, 59.85, 38.40, 35.87, 22.68.; νmax (neat, cm -1 ): 2942 , 1730 , 1684 , 1615 , 1429 , 1327 , 1287 , 1133 
4-Bromo-3-hydroxyfuran-2(5H)-one (3-Br-a)
To a solution of 3-hydroxyfuran-2(5H)-one (343 mg, 3.43 mmol) in MeCN (42 mL) and water (4.2 mL) NBS (611 mg, 3.43 mmol) was added and the mixture was stirred for 17 h at room temperature. Water (42 mL) was then added and the mixture was extracted with CH2Cl2 (1x40 mL and 5x20 mL). The combined extracts were dried (Na2SO4) and the solvents were evaporated. The residue was purified by column chromatography on silica gel (petroleum ether/EtOAc 10:1.5-10:2) to give 3-Br-a as a white solid (461 mg, 75%); mp 112-114 
4-Bromo-3-methoxyfuran-2(5H)-one (3-Br-b)
To a solution of 3-Br-a (153 mg, 0.85 mmol) in CHCl3 (2mL) Ag2O (237 mg, 1.02 mmol) and MeI (0.424 mL, 6.8mmol) were added and the mixture was heated at reflux for 45 min. The cooled mixture was filtered through a bed of Celite and the filtrate was evaporated. The residue was purified by column chromatography on silica gel (5-15% EtOAc in petroleum ether) to give 3-Br-b as a white solid (132 
4-Bromo-3-((tert-butyldimethylsilyl)oxy)furan-2(5H)-one (3-Br-c)
To a solution of 3-Br-a ,(461 mg, 2.58 mmol) and imidazole (281 mg, 4.13 mmol) in CH2Cl2 (13 mL) TBDMSCl (467 mg, 3.1 mmol) was added. After stirring at room temperature for 30 min, water (25 mL) was added, CH2Cl2 layer was separated and the aqueous phase was extracted with CH2Cl2 (2 x 15 mL). The combined extracts were washed with brine (12 mL), dried (Na2SO4) and concentrated. The residue was purified by column chromatography on silica gel (petroleum ether/EtOAc 60:1 to 50:1) to give 3-Br-c as a colorless oil,which solidified in refrigerator (687 mg, 91% 
4-Bromo-3-((tert-butyldiphenylsilyl)oxy)furan-2(5H)-one (3-Br-c´ )
To a solution of 3-Br-a ,(290 mg, 1.62 mmol) and imidazole (220 mg, 3.24 mmol) in CH2Cl2 (8 mL) TBDPCl (0.63 mL, 2.43 mmol) was added. After stirring at room temperature for 30 min, water (15 mL) was added, CH2Cl2 layer was separated and the aqueous phase was extracted with CH2Cl2 (2 x 10 mL). The combined extracts were washed with brine (10 mL), dried (Na2SO4) and concentrated. The residue was purified by column chromatography on silica gel (petroleum ether/EtOAc 50:1) to give 3-Br-c´ as a white solid (606 5, 140.7, 135.6, 131.9, 130.4, 127.8, 116.1, 69.6, 26.7, 19.8; νmax (KBr, cm -1 ): 2964 νmax (KBr, cm -1 ): , 2926 νmax (KBr, cm -1 ): , 2856 νmax (KBr, cm -1 ): , 1768 νmax (KBr, cm -1 ): , 1672 νmax (KBr, cm -1 ): , 1428 νmax (KBr, cm -1 ): , 1321 νmax (KBr, cm -1 ): , 1184 νmax (KBr, cm -1 ): , 1115 νmax (KBr, cm -1 ): , 1091 νmax (KBr, cm -1 ): , 1018 m/z (EI) 
4-Bromo-3-(methoxymethoxy)furan-2(5H)-one (3-Br-d)
To a solution of 3-Br-a (298 mg, 1.66 mmol) in CHCl2 (8.8 mL) dimetoxymethane (8.8 mL, 99.6 mmol) and P2O5 (1.06 g, 7.47 mmol) were added. After stirring at room temperature for 5 h the reaction mixture was poured into a cold saturated Na2CO3 solution. CH2Cl2 layer was separated and the aqueous phase was extracted with CH2Cl2 (2 x 12 mL). The combined extracts were washed with brine (10 mL), dried (Na2SO4) and concentrated. The residue was purified by column chromatography on silica gel (petroleum ether/EtOAc 10:1-10:1. 
